SCHEMBL118216

SCHEMBL118216

CCC(CC)(Oc1cc(O)c2c(=O)c(O)c(-c3ccccc3)oc2c1)P(=O)(O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 7/20 0.59
MEN1 O00255 6/20 0.59
KMT2A Q03164 6/20 0.59
CYP3A4 P08684 5/20 0.59
MAPT P10636 5/20 0.59
MAOA P21397 4/20 0.59
CYP1A1 P04798 4/20 0.59
CYP1A2 P05177 4/20 0.59
CYP1B1 Q16678 4/20 0.59
FTO Q9C0B1 4/20 0.59
XDH P47989 4/20 0.59
ADORA3 P0DMS8 3/20 0.59
CA12 O43570 3/20 0.59
BCHE P06276 3/20 0.59
CYP2D6 P10635 3/20 0.59
CYP2C9 P11712 3/20 0.59
ACHE P22303 3/20 0.59
CYP2C19 P33261 3/20 0.59
PPARG P37231 3/20 0.59
CA7 P43166 3/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL118852 0.85 ABCB1 (0.56) ABCB1MEN1KMT2ACYP3A4MAPT
SCHEMBL119434 0.81 MEN1 (0.64) ABCB1MEN1KMT2ACYP3A4MAPT
SCHEMBL174699 0.80 ADORA3 (0.60) ABCB1CYP3A4MAPTADORA3CYP2D6
Izalpinin SCHEMBL29974286 0.80 MAOA (0.83) ABCB1MEN1KMT2ACYP3A4MAPT
Izalpinin SCHEMBL7551775 0.80 MAOA (0.83) ABCB1MEN1KMT2ACYP3A4MAPT
SCHEMBL28106758 0.76 MEN1 (0.67) ABCB1MEN1KMT2ACYP3A4MAPT
Galangin SCHEMBL117225 0.75 MEN1 (1.00) ABCB1MEN1KMT2ACYP3A4MAPT
Galangin SCHEMBL29393121 0.75 MEN1 (1.00) ABCB1MEN1KMT2ACYP3A4MAPT
SCHEMBL28106756 0.75 ADORA3 (0.64) ABCB1MEN1KMT2ACYP3A4MAPT
SCHEMBL5054599 0.75 ABCB1 (0.65) ABCB1MEN1KMT2ACYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424541-A2 PHOSPHORYLATED AND PHOSPHONATED PYRONE ANALOGS FOR THERAPEUTIC TREATMENT Limerick BioPharma, Inc. (US) 2012-03-07 EP disclosed